NVAX Oct 2024 5.000 put
| Previous Close | 1.1400 |
| Open | 0.4700 |
| Bid | 0.4200 |
| Ask | 0.5200 |
| Strike | 5.00 |
| Expire Date | 2024-10-18 |
| Day's Range | 0.3400 - 0.4700 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1.4k |
Yahoo FinanceNovavax CEO on Sanofi deal: 'This is a new chapter in the history of our company'
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
- Yahoo Finance Video
Stock markets, China tariffs, Novavax and Sanofi: 3 Things
The major stock market indexes (^DJI, ^IXIC, ^GSPC) are on the road to closing out the first full trading week of May on a high note, alongside several of its European counterparts: the FTSE 100 (^FTSE), the DAX Performance Index (^GDAXI), and the CAC 40 (^FCHI). President Biden is reportedly set to announce updates on Trump-era trade tariffs on China. Novavax (NVAX) shares are skyrocketing over 110% on news of the biotech company's plans to licensing deal with Sanofi (SNY, SAN.PA) to co-commercialize its COVID-19 vaccine For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.
The TelegraphBank of England made ‘persistent and systematic’ errors, official admits
The Bank of England made “persistent and systematic” errors in its forecasts about inflation, one of its policymakers has said.
